Physician

Adriana Kaczaraj Malone, M.D.

According to 2025 Medicare claims, Adriana Malone, M.D. (NPI: 1285849489) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1750649612; TIN: 611661781) and primary practice location at 10029-6501. Malone is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Malone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 63 traditional Medicare patients, billed 255 HCPCS/CPT codes, and received $21,495 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 444 prescription claims across 40 beneficiaries totaling $617,461 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2017 DME data shows 24 claims. Open Payments data shows 1 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $29,356 to $21,495. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $759,915 and ending at $617,461. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	95	375	$29,356
2016	91	521	$48,041
2017	94	480	$45,333
2018	111	493	$46,839
2019	109	524	$46,742
2020	84	381	$33,567
2021	78	289	$28,977
2022	85	325	$34,476
2023	72	259	$27,860
2024	63	255	$21,495

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	64	423	$759,915
2016	44	508	$751,955
2017	45	537	$815,333
2018	40	559	$928,778
2019	50	628	$1,515,651
2020	31	350	$709,825
2021	37	411	$926,173
2022	37	466	$928,137
2023	35	352	$599,213
2024	40	444	$617,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	30	$922
2017	N/R	24	$223
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	23	99	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	31	65	$74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	13	31	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	15	444	$139,106
Prevymis	Letermovir	12	336	$86,052
Posaconazole	Posaconazole	29	870	$36,711
Atovaquone	Atovaquone	28	624	$14,838
Venclexta	Venetoclax	20	182	$7,731

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$31	Kite Pharma, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adriana Kaczaraj Malone, M.D.?

Tedicare shows public-source Medicare data for Adriana Kaczaraj Malone, M.D. (NPI 1285849489), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana Kaczaraj Malone, M.D. have ACO affiliation data?

Adriana Kaczaraj Malone, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Adriana Kaczaraj Malone, M.D.?

Adriana Kaczaraj Malone, M.D. is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1750649612) in the available physician profile data.

Does Adriana Kaczaraj Malone, M.D. have Open Payments data?

Adriana Kaczaraj Malone, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.